220
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Relationship Between Severity of Gastrointestinal Symptoms and Anxiety Symptoms in Patients with Chronic Gastrointestinal Disease: The Mediating Role of Illness Perception

, , , , , , & show all
Pages 4921-4933 | Received 05 Jul 2023, Accepted 26 Nov 2023, Published online: 05 Dec 2023

References

  • Ranasinghe N, Devanarayana NM, Rajindrajith S, et al. Functional gastrointestinal diseases and psychological maladjustment, personality traits and quality of life. BMC Gastroenterol. 2018;18(1):33. doi:10.1186/s12876-018-0760-8
  • Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome foundation global study. Gastroenterology. 2021;160(1):99–114.e3. doi:10.1053/j.gastro.2020.04.014
  • Neuendorf R, Harding A, Stello N, Hanes D, Wahbeh H. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80. doi:10.1016/j.jpsychores.2016.06.001
  • Fond G, Loundou A, Hamdani N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264(8):651–660. doi:10.1007/s00406-014-0502-z
  • Shah E, Rezaie A, Riddle M, Pimentel M. Psychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence? Ann Gastroenterol. 2014;27(3):224–230.
  • Barberio B, Zamani M, Black CJ, Savarino EV, Ford AC. Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(5):359–370. doi:10.1016/S2468-1253(21)00014-5
  • Babić E, Bevanda M, Karin M, et al. Anxiety, depression and personality types in patients with inflammatory bowel disease: comparisons with peptic ulcer and the general population. Psychiatr Danub. 2021;33(1):48–56. doi:10.24869/psyd.2021.48
  • Wu H, Liang G, Kong M, et al. The status and risk factors for anxiety/depression in patients with atrophic chronic gastritis: a cross-sectional study. Ann Palliat Med. 2022;11(10):3147–3159. doi:10.21037/apm-22-730
  • Ananthakrishnan AN. Personalizing therapy for inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol. 2013;7(6):549–558. doi:10.1586/17474124.2013.824693
  • Wen Z, Li X, Lu Q, et al. Health related quality of life in patients with chronic gastritis and peptic ulcer and factors with impact: a longitudinal study. BMC Gastroenterol. 2014;14(1):149. doi:10.1186/1471-230X-14-149
  • Ganz ML, Sugarman R, Wang R, Hansen BB, Håkan-Bloch J. The economic and health-related impact of crohn’s disease in the United States: evidence from a nationally representative survey. Inflamm Bowel Dis. 2016;22(5):1032–1041. doi:10.1097/MIB.0000000000000742
  • Moffitt TE, Harrington H, Caspi A, et al. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 2007;64(6):651–660. doi:10.1001/archpsyc.64.6.651
  • Beeler PE, Cheetham M, Held U, Battegay E. Depression is independently associated with increased length of stay and readmissions in multimorbid inpatients. Eur J Intern Med. 2020;73:59–66. doi:10.1016/j.ejim.2019.11.012
  • Perera MJ, Schneiderman N, Sotres-Alvarez D, Daviglus M, Mirabal SM, Llabre MM. Are anxious and depressive symptoms associated with gastrointestinal symptoms in the Hispanic community health study/study of Latinos (HCHS/SOL)? J Racial Ethn Health Disparities. 2021;8(3):712–722. doi:10.1007/s40615-020-00831-6
  • Marrie RA, Graff LA, Fisk JD, Patten SB, Bernstein CN. The relationship between symptoms of depression and anxiety and disease activity in IBD over time. Inflamm Bowel Dis. 2021;27(8):1285–1293. doi:10.1093/ibd/izaa349
  • Lach G, Schellekens H, Dinan TG, Cryan JF. Anxiety, depression, and the microbiome: a role for gut peptides. Neurother J Am Soc Exp Neurother. 2018;15(1):36–59. doi:10.1007/s13311-017-0585-0
  • Liu Y, Wang H, Gui S, et al. Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression. Transl Psychiatry. 2021;11(1):568. doi:10.1038/s41398-021-01689-w
  • Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4(8):632–642. doi:10.1016/S2468-1253(19)30089-5
  • Capuco A, Urits I, Hasoon J, et al. Current perspectives on gut microbiome dysbiosis and depression. Adv Ther. 2020;37(4):1328–1346. doi:10.1007/s12325-020-01272-7
  • Sun D, Ge X, Tang S, et al. Bacterial characteristics of intestinal tissues from patients with crohn’s disease. Front Cell Infect Microbiol. 2021;11:711680. doi:10.3389/fcimb.2021.711680
  • Spina A, Mazzarella C, Dallio M, et al. The lesson from the first Italian lockdown: Impacts on anxiety and depressive symptoms and sleep quality in patients with remission of inflammatory bowel disease. Rev Recent Clin Trials. 2022;17(2):109–119. doi:10.2174/1574887117666220328125720
  • Diefenbach MA, Leventhal H. The common-sense model of illness representation: theoretical and practical considerations. J Soc Distress Homeless. 1996;5(1):11–38. doi:10.1007/BF02090456
  • Eindor-Abarbanel A, Naftali T, Ruhimovich N, et al. Important relation between self-efficacy, sense of coherence, illness perceptions, depression and anxiety in patients with inflammatory bowel disease. Frontline Gastroenterol. 2021;12(7):601–607. doi:10.1136/flgastro-2020-101412
  • Knowles SR, Gass C, Macrae F. Illness perceptions in IBD influence psychological status, sexual health and satisfaction, body image and relational functioning: a preliminary exploration using structural equation modeling. J Crohns Colitis. 2013;7(9):e344–e350. doi:10.1016/j.crohns.2013.01.018
  • van der Have M, Fidder HH, Leenders M, et al. Self-reported disability in patients with inflammatory bowel disease largely determined by disease activity and illness perceptions. Inflamm Bowel Dis. 2015;21(2):369–377. doi:10.1097/MIB.0000000000000278
  • Dempster M, McCorry NK, Brennan E, Donnelly M, Murray LJ, Johnston BT. Do changes in illness perceptions predict changes in psychological distress among oesophageal cancer survivors? J Health Psychol. 2011;16(3):500–509. doi:10.1177/1359105310386633
  • Petrie KJ, Perry K, Broadbent E, Weinman J. A text message programme designed to modify patients’ illness and treatment beliefs improves self-reported adherence to asthma preventer medication. Br J Health Psychol. 2012;17(1):74–84. doi:10.1111/j.2044-8287.2011.02033.x
  • Sararoudi RB, Motmaen M, Maracy MR, Pishghadam E, Kheirabadi GR. Efficacy of illness perception focused intervention on quality of life, anxiety, and depression in patients with myocardial infarction. J Res Med Sci Off J Isfahan Univ Med Sci. 2016;21:125. doi:10.4103/1735-1995.196607
  • Gravina AG, Pellegrino R, Palladino G, et al. Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy. Brain-Appar Commun J Bacomics. 2023;2(1):2181101. doi:10.1080/27706710.2023.2181101
  • Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–637. doi:10.1016/j.jpsychores.2005.10.020
  • Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie KJ. A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol Health. 2015;30(11):1361–1385. doi:10.1080/08870446.2015.1070851
  • De Gucht V. Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients. Qual Life Res. 2015;24(8):1845–1856. doi:10.1007/s11136-015-0932-8
  • Knowles SR, Cook SI, Tribbick D. Relationship between health status, illness perceptions, coping strategies and psychological morbidity: a preliminary study with IBD stoma patients. J Crohns Colitis. 2013;7(10):e471–e478. doi:10.1016/j.crohns.2013.02.022
  • Kroenke K, Spitzer RL, Williams JBW, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317–325. doi:10.7326/0003-4819-146-5-200703060-00004
  • Luo Y, Keefer L. Role of psychological questionnaires in clinical practice and research within functional gastrointestinal disorders. Neurogastroenterol Motil. 2021;33(12):e14297. doi:10.1111/nmo.14297
  • Swinson RP. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid Based Med. 2006;11(6):184. doi:10.1136/ebm.11.6.184
  • Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi:10.1001/archinte.166.10.1092
  • Svedlund J, Sjödin I, Dotevall G. GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33(2):129–134. doi:10.1007/BF01535722
  • Kulich KR, Madisch A, Pacini F, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale (gsrs) and Quality Of Life In Reflux And Dyspepsia (QOLRAD) questionnaire in dyspepsia: a six-country study. Health Qual Life Outcomes. 2008;6:12. doi:10.1186/1477-7525-6-12
  • Kulich KR, Reguła J, Stasiewicz J, Jasinski B, Carlsson J, Wiklund I. Psychometric validation of the polish translation of the Gastrointestinal Symptom Rating Scale (gsrs) and Quality Of Life In Reflux And Dyspepsia (qolrad) questionnaire in patients with reflux disease. Pol Arch Med Wewn. 2005;113(3):241–249.
  • Mackinnon DP, Lockwood CM, Williams J. Confidence limits for the indirect effect: distribution of the product and resampling methods. Multivar Behav Res. 2004;39(1):99. doi:10.1207/s15327906mbr3901_4
  • Pinto-Sanchez MI, Ford AC, Avila CA, et al. Anxiety and depression increase in a stepwise manner in parallel with multiple fgids and symptom severity and frequency. Am J Gastroenterol. 2015;110(7):1038–1048. doi:10.1038/ajg.2015.128
  • Piacentino D, Cesarini M, Badiali D, Pallotta N, Biondi M, Corazziari ES. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome. Riv Psichiatr. 2019;54(2):75–83. doi:10.1708/3142.31248
  • Mussell M, Kroenke K, Spitzer RL, Williams JBW, Herzog W, Löwe B. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. J Psychosom Res. 2008;64(6):605–612. doi:10.1016/j.jpsychores.2008.02.019
  • Mikocka-Walus A, Turnbull D, Moulding N, Wilson I, Andrews JM, Holtmann G. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. J Gastroenterol Hepatol. 2008;23(7 Pt 1):1137–1143. doi:10.1111/j.1440-1746.2007.05245.x
  • Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012;10(11):735–742. doi:10.1038/nrmicro2876
  • Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci. 2013;36(5):305–312. doi:10.1016/j.tins.2013.01.005
  • Lee Y, Kim YK. Understanding the connection between the gut-brain axis and stress/anxiety disorders. Curr Psychiatry Rep. 2021;23(5):22. doi:10.1007/s11920-021-01235-x
  • Fairbrass KM, Lovatt J, Barberio B, Yuan Y, Gracie DJ, Ford AC. Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut. 2022;71(9):1773–1780. doi:10.1136/gutjnl-2021-325985
  • Agirman G, Yu KB, Hsiao EY. Signaling inflammation across the gut-brain axis. Science. 2021;374(6571):1087–1092. doi:10.1126/science.abi6087
  • Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013. doi:10.1152/physrev.00018.2018
  • Guida F, Turco F, Iannotta M, et al. Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav Immun. 2018;67:230–245. doi:10.1016/j.bbi.2017.09.001
  • Liang L, Zhou H, Zhang S, Yuan J, Wu H. Effects of gut microbiota disturbance induced in early life on the expression of extrasynaptic GABA-A receptor α5 and δ subunits in the hippocampus of adult rats. Brain Res Bull. 2017;135:113–119. doi:10.1016/j.brainresbull.2017.09.014
  • Hoban AE, Moloney RD, Golubeva AV, et al. Behavioural and neurochemical consequences of chronic gut microbiota depletion during adulthood in the rat. Neuroscience. 2016;339:463–477. doi:10.1016/j.neuroscience.2016.10.003
  • Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in crohn’s disease: medical treatment. J Crohns Colitis. 2020;14(1):4–22. doi:10.1093/ecco-jcc/jjz180
  • Magro F, Gionchetti P, Eliakim R, et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670. doi:10.1093/ecco-jcc/jjx008
  • Marinelli C, Savarino E, Inferrera M, et al. Factors influencing disability and quality of life during treatment: a cross-sectional study on IBD patients. Gastroenterol Res Pract. 2019;2019:5354320. doi:10.1155/2019/5354320
  • Mules TC, Swaminathan A, Hirschfeld E, et al. The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the stress, anxiety and depression with disease activity (sadd) study. Aliment Pharmacol Ther. 2022;55(2):201–211. doi:10.1111/apt.16616
  • Dhaliwal HS, Singh R, Abraham AM, et al. Perception of illness and its association with treatment willingness in patients with newly diagnosed nonalcoholic fatty liver disease. Dig Dis Sci. 2021;66(12):4197–4207. doi:10.1007/s10620-020-06794-2
  • Kucukarslan SN. A review of published studies of patients’ illness perceptions and medication adherence: lessons learned and future directions. Res Soc Adm Pharm. 2012;8(5):371–382. doi:10.1016/j.sapharm.2011.09.002
  • Janssens ACJW, van Doorn PA, de Boer JB, van der Meché FGA, Passchier J, Hintzen RQ. Perception of prognostic risk in patients with multiple sclerosis: the relationship with anxiety, depression, and disease-related distress. J Clin Epidemiol. 2004;57(2):180–186. doi:10.1016/S0895-4356(03)00260-9
  • Kunschitz E, Friedrich O, Schöppl C, Maitz J, Sipötz J. Illness perception patterns in patients with coronary artery disease. Psychol Health Med. 2017;22(8):940–946. doi:10.1080/13548506.2016.1271439
  • Zhang N, Fielding R, Soong I, et al. Illness perceptions as predictors of psychological distress among head and neck cancer survivors: a longitudinal study. Head Neck. 2018;40(11):2362–2371. doi:10.1002/hed.25343
  • McCorry NK, Dempster M, Quinn J, et al. Illness perception clusters at diagnosis predict psychological distress among women with breast cancer at 6 months post diagnosis. Psychooncology. 2013;22(3):692–698. doi:10.1002/pon.3054
  • Kantidakis JD, Moulding R, Knowles SR. Psychological mediators of psychological distress and quality of life in inflammatory bowel disease. J Psychosom Res. 2021;149:110596. doi:10.1016/j.jpsychores.2021.110596
  • Mikocka-Walus A, Andrews JM, Bampton P. Cognitive behavioral therapy for IBD. Inflamm Bowel Dis. 2016;22(2):E5–E6. doi:10.1097/MIB.0000000000000672
  • Chilcot J, Moss-Morris R. Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention. Behav Res Ther. 2013;51(10):690–695. doi:10.1016/j.brat.2013.07.007
  • Fischer MJ, Wiesenhaan ME, Does-den Heijer A, Kleijn WC, Nortier JWR, Kaptein AA. From despair to hope: a longitudinal study of illness perceptions and coping in a psycho-educational group intervention for women with breast cancer. Br J Health Psychol. 2013;18(3):526–545. doi:10.1111/j.2044-8287.2012.02100.x